Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | RGS12 | O14924 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL144907 | 0.98 | KMT2A (0.47) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| Hydrochloric Acid SCHEMBL17847864 | 0.98 | KMT2A (0.43) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| Sulfuric Acid SCHEMBL141470 | 0.89 | KMT2A (0.38) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| Sulfuric Acid SCHEMBL141469 | 0.89 | KMT2A (0.38) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| SCHEMBL19037386 | 0.84 | KMT2A (0.50) | KMT2AMEN1RCE1RAB9AHPGD | |
| SCHEMBL14621784 | 0.83 | KMT2A (0.50) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| SCHEMBL11925329 | 0.83 | MEN1 (0.64) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| SCHEMBL290669 | 0.83 | KMT2A (0.42) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| SCHEMBL10595348 | 0.82 | SMN1; SMN2 (0.40) | KMT2AMEN1RCE1ALDH1A1RAB9A | |
| SCHEMBL11926229 | 0.82 | ALDH1A1 (0.45) | KMT2AMEN1RCE1ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233801-B1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | OREAL (FR) | 2022-06-08 | — | — | EP | claimed |
| EP-3233801-B1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | OREAL (FR) | 2022-06-08 | — | — | EP | disclosed |
| CN-106999394-B | Use, composition and implementation method of specific pyridinium salt for treating keratin materials | 欧莱雅 | 2021-09-24 | — | — | CN | disclosed |
| US-10765615-B2 | Use of particular pyridinium salts for the treatment of keratin substances, compositions and implementation methods | L'OREAL (FR) | 2020-09-08 | — | — | US | disclosed |
| EP-2263642-B1 | Colouring bleaches | HENKEL AG & CO KGAA (DE) | 2020-04-15 | — | — | EP | disclosed |
| US-20170340543-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | L'OREAL (FR) | 2017-11-30 | — | — | US | disclosed |
| US-20170340543-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | L'OREAL (FR) | 2017-11-30 | — | — | US | disclosed |
| WO-2016097413-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | L'OREAL (FR) | 2016-06-23 | — | — | WO | disclosed |
| US-8137412-B2 | Bleaching with concomitant hair tonicizing | HENKEL AG & CO. KGAA (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20110232669-A1 | Bleaching with Concomitant Hair Tonicizing | HENKEL AG & CO. KGAA (DE) | 2011-09-29 | — | — | US | disclosed |
| EP-2355778-A2 | IMPROVED BEACHING WITH CONCOMITANT HAIR TONICIZING | Henkel AG & Co. KGaA (DE) | 2011-08-17 | — | — | EP | disclosed |
| US-7981166-B2 | Bleaching agent having cationic acyl pyridinium derivatives, co-bleaching activators and hydrogen peroxide | HENKEL AG & CO. KGAA (DE) | 2011-07-19 | — | — | US | disclosed |
| US-20110047712-A1 | BLEACHING AGENT HAVING CATIONIC ACYL PYRIDINIUM DERATIVES, CO-BLEACHING ACTIVATORS AND HYDROGEN PEROXIDE | HENKEL AG & CO. KGAA (DE) | 2011-03-03 | — | — | US | disclosed |
| WO-2010066720-A2 | IMPROVED BEACHING WITH CONCOMITANT HAIR TONICIZING | HENKEL AG & CO. KGAA (DE) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010054981-A2 | COMBINATION OF CATIONIC BLEACH ACTIVATORS AND DYES | HENKEL AG & CO. KGAA (DE) | 2010-05-20 | — | — | WO | disclosed |
| WO-2009135700-A1 | BLEACHING AGENT HAVING CATIONIC ACYL PYRIDINIUM DERIVATIVES, CO-BLEACHING ACTIVATORS, AND HYDROGEN PEROXIDE | HENKEL AG & CO. KGAA (DE) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110047712-A1 | BLEACHING AGENT HAVING CATIONIC ACYL PYRIDINIUM DERATIVES, CO-BLEACHING ACTIVATORS AND HYDROGEN PEROXIDE | F12, KRT18, H1-3 | KMT2A 1559/4885MEN1 4718/4885RCE1 4420/4885 |
| US-20170340543-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | KRT18, PLPBP, PNPO | KMT2A 1799/4885MEN1 2850/4885RCE1 4160/4885 |
| US-10765615-B2 | Use of particular pyridinium salts for the treatment of keratin substances, compositions and implementation methods | KRT18, PLPBP, PNPO | KMT2A 1799/4885MEN1 2850/4885RCE1 4160/4885 |
| US-20110232669-A1 | Bleaching with Concomitant Hair Tonicizing | KRT18, KAT7, KAT2B | KMT2A 480/4885MEN1 4676/4885RCE1 4824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.